Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

215
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
215
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

127
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
127
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

162
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
162
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

290
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
290
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

207
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
207
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

791
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
791

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Growth Differentiation Factor-15 Could Predict Decreased Hemoglobin in Tuberculosis Treated With Linezolid-Containing Regimen.

The clinical respiratory journal·2026
Same author

The ghost of tuberculosis past.

Nature medicine·2026
Same author

Lungs Are Only Half the Story: Programmatic Shifts to Prioritize Pediatric Extrapulmonary Tuberculosis Detection in High-Burden Settings.

Journal of the Pediatric Infectious Diseases Society·2026
Same author

Tuberculosis infection tests for contact screening in Brazil: a cost-effectiveness analysis.

Lancet regional health. Americas·2026
Same author

Age and sex differences in paediatric tuberculosis care for child contacts.

Journal of global health·2026
Same author

Diagnostic Performance of New Commercial IGRAs for Mycobacterium tuberculosis Infection: An updated Systematic Review and Meta-analysis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
See all related articles

Related Experiment Video

Updated: May 23, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K

Tuberculosis.

Anete Trajman1, Jonathon R Campbell2, Tenzin Kunor3

  • 1Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; McGill International TB Centre, Montreal, QC, Canada.

Lancet (London, England)
|March 8, 2025
PubMed
Summary
This summary is machine-generated.

Tuberculosis (TB) is a global health threat. Early diagnosis and comprehensive, person-centered care, including managing risk factors and comorbidities, are crucial for effective treatment and prevention of this airborne disease.

More Related Videos

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.0K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

13.8K

Related Experiment Videos

Last Updated: May 23, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.0K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

13.8K

Area of Science:

  • Global Health
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Tuberculosis (TB) remains a significant global cause of mortality.
  • Airborne transmission poses a risk to everyone, particularly in high-incidence areas.
  • Progression to active TB is accelerated by factors like malnutrition, immunosuppression, and comorbidities such as diabetes.

Purpose of the Study:

  • To review the current understanding of tuberculosis transmission, diagnosis, treatment, and prevention.
  • To highlight the importance of person-centered care in managing TB and its associated risk factors.
  • To emphasize the need for ongoing research in diagnostics and therapeutics for TB elimination.

Main Methods:

  • Review of current literature on tuberculosis epidemiology, clinical presentation, and management strategies.
  • Analysis of diagnostic approaches including sputum examination, molecular tests, and chest radiography.
  • Examination of treatment regimens, prevention methods, and the role of managing comorbidities and social determinants.

Main Results:

  • Tuberculosis diagnosis requires a high index of suspicion, with prompt identification aided by sputum tests and radiography.
  • Effective treatment involves short-term regimens (≤6 months) for drug-susceptible TB, with longer durations for drug-resistant forms.
  • Comprehensive care addressing malnutrition, substance use, and comorbidities like diabetes and HIV is vital for successful outcomes and preventing long-term complications.

Conclusions:

  • Successful tuberculosis management hinges on early diagnosis, tailored treatment, and holistic, person-centered care.
  • Addressing social determinants and comorbidities is essential for effective TB control and prevention.
  • Advancements in diagnostics and therapeutics, alongside improved preventive strategies, are critical for achieving global tuberculosis elimination.